Inotiv, Inc. Comparables

Find the most relevant public market comparables for Inotiv, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.

Company Overview

Inotiv, Inc. is a leading contract research organization (CRO) providing nonclinical and analytical drug discovery and development services, research models, and related products and services. The company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians, primarily for small molecule drug candidates, biotherapeutics, and biomedical devices. They also sell research-quality animals and diets to pharmaceutical and medical device industries, academia, and government clients.

Business Model

Contract Research Organization (CRO) offering services across the drug development lifecycle, including discovery, preclinical testing, and analytical services. They also provide research models (live animals), lab animal diets, bedding, and support services.

Target Customers

Pharmaceutical and medical device companies, biotechnology companies, academia, and government clients.

Specific Focus

Nonclinical and analytical drug discovery and development services, research models and related products and services for pharmaceutical, medical device, and biotechnology companies.

Location

West Lafayette, Indiana

CEO

Robert Leasure Jr.

Industry

Life sciences

Sub Sector

Contract Research Organizations (CROs)

3yr Revenue Growth

847%

Public Market Comparables

Below are the key valuation metrics for companies similar to Inotiv, Inc. in the Pharmaceutical industry sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.

Looking for a comprehensive compset for Inotiv, Inc.? Our platform provides detailed analysis of Inotiv, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Inotiv, Inc. compset by trying our platform today.

EV/Revenue Multiple

Min

0.0x

Median

0.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details

EV/EBITDA Multiple

Min

00.0x

Median

00.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details
Screenshot of CompSetFinder showing Inotiv, Inc. comps with valuation metrics like EV/Revenue, EV/EBITDA, and P/E

Unlock the Full Inotiv, Inc. Compset

As a leading player in the Life sciences industry within the Pharmaceutical industry sector, Inotiv, Inc. operates in the specialized Contract Research Organizations (CROs) sub-sector. Understanding how Inotiv, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.

Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Contract Research Organizations (CROs) space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.

Get Your Custom Comparable Analysis

Need a more detailed analysis of Inotiv, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.

Try CompsetFinder Free